Physician profile
Wolfgang Leesch
NPI 1255453320
$26,105.72
in general payments reported to CMS, 2019-2025
22 companies · $5,428 in 2025
The $5,428 reported for 2025 was more than what 88% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,097 · 2020: $1,146 · 2021: $1,712 · 2022: $3,835 · 2023: $5,076 · 2024: $2,811 · 2025: $5,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,628 · Travel and Lodging: $4,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,627.54 |
| Travel and Lodging | $4,687.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $10,313.70 | 2019-2025 | Smart Coil, Penumbra System, Red 72 |
| Imperative Care, INC | $5,995.43 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm, Zoom Reperfusion Catheter |
| Medtronic, INC. | $4,100.47 | 2022-2025 | Solitaire X, Pipeline, Rist |
| Stryker Corporation | $1,667.65 | 2019-2024 | Surpass Evolve, 1788, Axs Vecta 71 |
| Medical Device Business Services, INC. | $993.26 | 2022 | |
| Depuy Synthes Sales INC. | $801.05 | 2019-2025 | Trufill, Prowler, Embotrap |
| Rapid Medical Ltd | $291.25 | 2023-2024 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Microvention, INC. | $272.08 | 2025 | Web Aneurysm Embolization System |
| Medtronic USA, INC. | $269.50 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $219.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $191.87 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $191.60 | 2019 | |
| Phenox INC. | $165.13 | 2022 | |
| W. L. Gore & Associates, INC. | $146.85 | 2025 | Gore Cardioform Septal Occluder |
| Amgen INC. | $121.26 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $98.10 | 2019 | |
| Pfizer INC. | $85.28 | 2024-2025 | |
| Scientia Vascular | $78.82 | 2023 | |
| Abbott Laboratories | $49.88 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.39 | 2019 | |
| Portola Pharmaceuticals, LLC | $19.02 | 2019 | |
| Asahi Intecc USA, INC. | $10.37 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wolfgang Leesch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.